343 related articles for article (PubMed ID: 16034902)
21. Oral steroid-sparing effect of two doses of nebulized fluticasone propionate and placebo in patients with severe chronic asthma.
Westbroek J; Saarelainen S; Laher M; O'Brien J; Barnacle H; Efthimiou J
Respir Med; 1999 Oct; 93(10):689-99. PubMed ID: 10581657
[TBL] [Abstract][Full Text] [Related]
22. High dose versus low dose inhaled corticosteroid as initial starting dose for asthma in adults and children.
Powell H; Gibson PG
Cochrane Database Syst Rev; 2004; 2004(2):CD004109. PubMed ID: 15106238
[TBL] [Abstract][Full Text] [Related]
23. Fluticasone versus HFA-beclomethasone dipropionate for chronic asthma in adults and children.
Lasserson TJ; Cates CK; Jones AB; Steele EH; White J
Cochrane Database Syst Rev; 2006 Apr; 2006(2):CD005309. PubMed ID: 16625634
[TBL] [Abstract][Full Text] [Related]
24. Fluticasone propionate compared with budesonide: a double-blind trial in asthmatic children using powder devices at a dosage of 400 microg x day(-1).
Hoekx JC; Hedlin G; Pedersen W; Sorva R; Hollingworth K; Efthimiou J
Eur Respir J; 1996 Nov; 9(11):2263-72. PubMed ID: 8947070
[TBL] [Abstract][Full Text] [Related]
25. Inhaled beclomethasone versus budesonide for chronic asthma.
Adams N; Bestall JM; Jones PW
Cochrane Database Syst Rev; 2002; 2002(1):CD003530. PubMed ID: 11869673
[TBL] [Abstract][Full Text] [Related]
26. Cost effectiveness of fluticasone propionate plus salmeterol versus fluticasone propionate plus montelukast in the treatment of persistent asthma.
O'Connor RD; Nelson H; Borker R; Emmett A; Jhingran P; Rickard K; Dorinsky P
Pharmacoeconomics; 2004; 22(12):815-25. PubMed ID: 15294013
[TBL] [Abstract][Full Text] [Related]
27. Clinical dose-response relationship of fluticasone propionate in adults with asthma.
Masoli M; Weatherall M; Holt S; Beasley R
Thorax; 2004 Jan; 59(1):16-20. PubMed ID: 14694240
[TBL] [Abstract][Full Text] [Related]
28. Dose-response relation of inhaled fluticasone propionate in adolescents and adults with asthma: meta-analysis.
Holt S; Suder A; Weatherall M; Cheng S; Shirtcliffe P; Beasley R
BMJ; 2001 Aug; 323(7307):253-6. PubMed ID: 11485952
[TBL] [Abstract][Full Text] [Related]
29. Efficacy and tolerability of fluticasone propionate/salmeterol administered twice daily via hydrofluoroalkane 134a metered-dose inhaler in adolescent and adult patients with persistent asthma: a randomized, double-blind, placebo-controlled, 12-week study.
Nathan RA; Rooklin A; Schoaf L; Scott C; Ellsworth A; House K; Dorinsky P
Clin Ther; 2006 Jan; 28(1):73-85. PubMed ID: 16490581
[TBL] [Abstract][Full Text] [Related]
30. Add-on salmeterol compared to double dose fluticasone in pediatric asthma: a double-blind, randomized trial (VIAPAED).
Gappa M; Zachgo W; von Berg A; Kamin W; Stern-Sträter C; Steinkamp G;
Pediatr Pulmonol; 2009 Nov; 44(11):1132-42. PubMed ID: 19824054
[TBL] [Abstract][Full Text] [Related]
31. Beclomethasone at different doses for chronic asthma (review).
Adams N; Bestall J; Jones P
Cochrane Database Syst Rev; 2001; 1999(1):CD002879. PubMed ID: 11279769
[TBL] [Abstract][Full Text] [Related]
32. Addition of inhaled long-acting beta2-agonists to inhaled steroids as first line therapy for persistent asthma in steroid-naive adults.
Ni CM; Greenstone IR; Ducharme FM
Cochrane Database Syst Rev; 2005 Apr; (2):CD005307. PubMed ID: 15846751
[TBL] [Abstract][Full Text] [Related]
33. Holding chambers versus nebulisers for inhaled steroids in chronic asthma.
Cates CJ; Bestall J; Adams N
Cochrane Database Syst Rev; 2006 Jan; 2006(1):CD001491. PubMed ID: 16437434
[TBL] [Abstract][Full Text] [Related]
34. Combination fluticasone and salmeterol versus fixed dose combination budesonide and formoterol for chronic asthma in adults and children.
Lasserson TJ; Cates CJ; Ferrara G; Casali L
Cochrane Database Syst Rev; 2008 Jul; (3):CD004106. PubMed ID: 18646100
[TBL] [Abstract][Full Text] [Related]
35. Inhaled corticosteroids versus sodium cromoglycate in children and adults with asthma.
Guevara JP; Ducharme FM; Keren R; Nihtianova S; Zorc J
Cochrane Database Syst Rev; 2006 Apr; 2006(2):CD003558. PubMed ID: 16625584
[TBL] [Abstract][Full Text] [Related]
36. Airway and systemic effects of hydrofluoroalkane formulations of high-dose ciclesonide and fluticasone in moderate persistent asthma.
Lee DK; Fardon TC; Bates CE; Haggart K; McFarlane LC; Lipworth BJ
Chest; 2005 Mar; 127(3):851-60. PubMed ID: 15764767
[TBL] [Abstract][Full Text] [Related]
37. Long-acting beta2-agonists versus anti-leukotrienes as add-on therapy to inhaled corticosteroids for chronic asthma.
Ducharme FM; Lasserson TJ; Cates CJ
Cochrane Database Syst Rev; 2006 Oct; (4):CD003137. PubMed ID: 17054161
[TBL] [Abstract][Full Text] [Related]
38. Salmeterol/fluticasone propionate vs. double dose fluticasone propionate on lung function and asthma control in children.
de Blic J; Ogorodova L; Klink R; Sidorenko I; Valiulis A; Hofman J; Bennedbaek O; Anderton S; Attali V; Desfougeres JL; Poterre M
Pediatr Allergy Immunol; 2009 Dec; 20(8):763-71. PubMed ID: 19239660
[TBL] [Abstract][Full Text] [Related]
39. Dose-ranging study of mometasone furoate dry powder inhaler in the treatment of moderate persistent asthma using fluticasone propionate as an active comparator.
O'Connor B; Bonnaud G; Haahtela T; Luna JM; Querfurt H; Wegener T; Lutsky BN
Ann Allergy Asthma Immunol; 2001 Apr; 86(4):397-404. PubMed ID: 11345282
[TBL] [Abstract][Full Text] [Related]
40. Fluticasone propionate in asthma: a long term dose comparison study.
Verona E; Petrov D; Cserhati E; Hofman J; Geppe N; Medley H; Hughes S
Arch Dis Child; 2003 Jun; 88(6):503-9. PubMed ID: 12765916
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
